Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)
Status:
Completed
Trial end date:
2018-05-07
Target enrollment:
Participant gender:
Summary
This trial consists of 3 parts: a pilot safety phase, a pivotal randomized controlled phase,
and an open-label extension phase. The pilot phase only will be described in this record. 2
cohorts of 5 participants will be enrolled sequentially. All participants will receive
GWP42003-P.